alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 70, Number 20 (Tuesday, February 1, 2005)]
[Notices]
[Page 5194]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-1836]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C.. appendix 2), notice is hereby given of the following 
meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Minority Programs Review Committee, MARC 
Review Subcommittee A.
    Date: February 17, 2005.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave, 
Bethesda, MD 20814.
    Contact Person: Richard I. Martinez, PhD, Scientific Review 
Administrator, Office of Scientific Review, National Institute of 
General Medical Sciences, National Institutes of Health, Natcher 
Building, Room 3AN-12B, 45 Center Drive MSC 6200, Bethesda, MD 
20892-6200, 301-594-2489, <a href="/cdn-cgi/l/email-protection#16647b20257056787f7e38717960"><span class="__cf_email__" data-cfemail="89fbe4bfbaefc9e7e0e1a7eee6ff">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93.96, 
Special Minority Initiatives, National Institutes of Health, HHS)

    Dated: January 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-1836 Filed 1-31-05; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3973 Referred in Senate (RFS)]

113th CONGRESS
  2d Session
                                H. R. 3973

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 24, 2014

  Received; read twice and referred to the Committee on the Judiciary

_______________________________________________________________________

                                 AN ACT

 
         To amend section 530D of title 28, United States Code.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Faithful Execution of the Law Act of 
2014''.

SEC. 2. AMENDMENT TO SECTION 530D OF TITLE 28, UNITED STATES CODE.

    Section 530D(a)(1)(A) of title 28, United States Code, is amended--
            (1) by inserting ``or any other Federal officer'' before 
        ``establishes or implements a formal or informal policy''; and
            (2) in clause (i), by striking ``on the grounds that such 
        provision is unconstitutional'' and inserting ``and state the 
        grounds for such policy''.

            Passed the House of Representatives March 13, 2014.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.
```
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[S. 777 Introduced in Senate (IS)]

110th CONGRESS
  1st Session
                                 S. 777

  To repeal the imposition of withholding on certain payments made to 
                    vendors by government entities.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 6, 2007

   Mr. Craig introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To repeal the imposition of withholding on certain payments made to 
                    vendors by government entities.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Withholding Tax Relief Act of 
2007''.

SEC. 2. REPEAL OF IMPOSITION OF WITHHOLDING ON CERTAIN PAYMENTS MADE TO 
              VENDORS BY GOVERNMENT ENTITIES.

    The amendment made by section 511 of the Tax Increase Prevention 
and Reconciliation Act of 2005 is repealed and the Internal Revenue 
Code of 1986 shall be applied as if such amendment had never been 
enacted.
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE>      5
<LEGEND>       THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION
               EXTRACTED FROM THE TRANS ENERGY, INC. FINANCIAL
               STATEMENTS FOR THE PERIOD ENDED DECEMBER 31, 1997
               AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
               SUCH FINANCIAL STATEMENTS.
<MULTIPLIER>   1
       
<S>                                <C>
<PERIOD-TYPE>                      YEAR
<FISCAL-YEAR-END>                  DEC-31-1997
<PERIOD-START>                     JAN-1-1997
<PERIOD-END>                       DEC-31-1997
<CASH>                                     185,881
<SECURITIES>                                     0
<RECEIVABLES>                              175,161
<ALLOWANCES>                                     0
<INVENTORY>                                      0
<CURRENT-ASSETS>                           362,483
<PP&E>                                   7,055,521
<DEPRECIATION>                           1,742,136
<TOTAL-ASSETS>                           5,680,601
<CURRENT-LIABILITIES>                    2,284,912
<BONDS>                                    792,387
<PREFERRED-MANDATORY>                            0
<PREFERRED>                                      0
<COMMON>                                     5,663
<OTHER-SE>                              10,746,979
<TOTAL-LIABILITY-AND-EQUITY>             5,680,601
<SALES>                                  1,115,037
<TOTAL-REVENUES>                         1,115,037
<CGS>                                      748,757
<TOTAL-COSTS>                            2,731,857
<OTHER-EXPENSES>                           370,138
<LOSS-PROVISION>                                 0
<INTEREST-EXPENSE>                         281,867
<INCOME-PRETAX>                        (1,986,958)
<INCOME-TAX>                                     0
<INCOME-CONTINUING>                    (1,986,958)
<DISCONTINUED>                            (42,492)
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                            (2,029,450)
<EPS-PRIMARY>                                 (.44)
<EPS-DILUTED>                                 (.44)
        

</TABLE>
STATE v. Nijel Ramsey LEE.

No. 416P15-1.

Supreme Court of North Carolina.

Jan. 28, 2016.

Robert C. Montgomery, Special Deputy Attorney General, for State of North Carolina.

Nijel Ramsey Lee, Brunswick, for Lee, Nijel Ramsey.

R. Andrew Murray, District Attorney, for State of North Carolina.

The following order has been entered on the motion filed on the 14th of December 2015 by Defendant for Notice of Appeal:

> "Motion Dismissed by order of the Court in conference, this the 28th of January 2016."
**EXHIBIT 31.2****CERTIFICATION OF CHIEF FINANCIAL OFFICER**I, James R. Kupferschmid, certify that:1. I have reviewed this quarterly report on Form 10-Q of Kitty Hawk, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material informationrelating to the registrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which this report is beingprepared;  (b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controlsand procedures, as of the end of the period covered by this report based on such evaluation;and  (c) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (the registrant’sfourth fiscal quarter in the case of an annual report) that has materially affected, or isreasonably likely to materially affect, the registrant’s internal control over financialreporting; and5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of registrant’s board of directors (or persons performing the equivalentfunctions): (a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and report financial information; and  (b) Any fraud, whether or not material, that involves management or other employees who havea significant role in the registrant’s internal control over financial reporting.        May 15, 2007 By:  /s/ JAMES R. KUPFERSCHMID    James R. Kupferschmid    Vice President and Chief Financial Officer
| /s/      Harry S. Palmin                                                   |   |   |        |   |
|----------------------------------------------------------------------------|--------|--------|--------|--------|
| Harry      S. Palmin                                                       |   |   |        |   |
| President,      Chief Executive Officer (Principal      Executive Officer) |   |   |        |   |
|                                                                       |   |   |   |   |
| Date:      November 19, 2010                                               |   |   |   |   |

| /s/      Joanne M. Protano                                                     |   |   |        |   |
|--------------------------------------------------------------------------------|--------|--------|--------|--------|
| Joanne      M. Protano                                                         |   |   |        |   |
| Chief      Financial Officer (Principal      Financial and Accounting Officer) |   |   |        |   |
|                                                                           |   |   |   |   |
| Date:      November 19, 2010                                                   |   |   |   |   |

----
# C_2011269EN.01004401.xml

| 10.9.2011 | EN | Official Journal of the European Union | C 269/44 |
| --- | --- | --- | --- |

10.9.2011

EN

Official Journal of the European Union

C 269/44

---

Judgment of the General Court of 13 July 2011 — Schindler Holding and Others v Commission

(Case T-138/07) (1)

1

(Competition - Agreements, decisions and concerted practices - Market for the installation and maintenance of elevators and escalators - Decision finding an infringement of Article 81 EC - Bid-rigging - Market sharing - Price fixing)

2011/C 269/96

Language of the case: German

Parties

Parties

Applicants: Schindler Holding Ltd (Hergiswil, Switzerland); Schindler Management AG (Ebikon, Switzerland); Schindler SA (Brussels, Belgium); Schindler Deutschland Holding GmbH (Berlin, Germany); Schindler Sàrl (Luxembourg, Luxembourg); and Schindler Liften BV (The Hague, Netherlands) (represented by: R. Bechtold, W. Bosch, U. Soltész and S. Hirsbrunner, lawyers)

Applicants:

Defendant: European Commission (represented by: K. Mojzesowicz and R. Sauer, Agents)

Defendant:

Intervener in support of the defendant: Council of the European Union (represented by: M. Simm and G. Kimberley, Agents)

Intervener in support of the defendant

Re:

Re:

Application for annulment of Commission Decision C(2007) 512 final of 21 February 2007 relating to a proceeding under Article 81 [EC] (Case COMP/E-1/38.823 — Elevators and Escalators) or, in the alternative, reduction of the amounts of the fines imposed on the applicants.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Declares that it is unnecessary to rule on the action in so far as it has been brought by Schindler Management AG; |
| --- | --- |

1.

Declares that it is unnecessary to rule on the action in so far as it has been brought by Schindler Management AG;

| 2. | Dismisses the action as to the remainder; |
| --- | --- |

2.

Dismisses the action as to the remainder;

| 3. | Orders Schindler Holding Ltd, Schindler SA, Schindler Deutschland Holding GmbH, Schindler Sàrl and Schindler Liften BV to pay the costs; |
| --- | --- |

3.

Orders Schindler Holding Ltd, Schindler SA, Schindler Deutschland Holding GmbH, Schindler Sàrl and Schindler Liften BV to pay the costs;

| 4. | Orders Schindler Management to bear its own costs; |
| --- | --- |

4.

Orders Schindler Management to bear its own costs;

| 5. | Orders the Council of the European Union to bear its own costs. |
| --- | --- |

5.

Orders the Council of the European Union to bear its own costs.

---

(1)  OJ C 155, 7.7.2007.

1

---
Afortunado RODRIGUEZ, Plaintiff, v. Karen BECKWITH, Defendant.

No. COA15-1021.

Court of Appeals of North Carolina.

May 17, 2016.

**CASE REPORTED WITHOUT PUBLISHED OPINION**

Reversed and Remanded.
Filed 9/20/17 by Clerk of Supreme Court

IN THE SUPREME COURT

STATE OF NORTH DAKOTA

2017 ND 228

In the Interest of Jane Doe

William Pryatel, M.D., Petitioner and Appellee

v.

Jane Doe, Respondent and Appellant

No. 20170322

Appeal from the District Court of Stutsman County, Southeast Judicial District, the Honorable Jay A. Schmitz, Judge.

AFFIRMED.

Per Curiam.

Kara E. Brinster, Special Assistant Attorney General, Jamestown, ND, for petitioner and appellee; on brief.

Andrew Marquart, Fargo, ND, for respondent and appellant; on brief.

Interest of Jane Doe

No. 20170322

Per Curiam.

[¶1]Jane Doe appealed the district court’s order for hospitalization and involuntary treatment with medication.  She argues the district court erred in finding her mentally ill and requiring treatment.  She also argues the district court erred in granting the request to treat with medications.  We conclude the district court’s findings are supported by clear and convincing evidence and are not clearly erroneous.  We affirm under N.D.R.App.P. 35.1(a)(2).

[¶2]Gerald W. VandeWalle, C.J.

Jon J. Jensen

Jerod E. Tufte

Daniel J. Crothers

Lisa Fair McEvers
[Federal Register Volume 70, Number 180 (Monday, September 19, 2005)]
[Notices]
[Pages 54952-54953]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-18531]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Office for Women's Services; Notice of a Meeting

    Pursuant to Public Law 92-463, notice is hereby given of a SAMHSA 
Advisory Committee for Women's Services meeting to be held in September 
2005.
    The meeting will be open and include discussions around the 
activities of SAMHSA's Matrix and women involving women and trauma/
violence, and developing short reports as they relate to mental health 
and substance abuse. Also, there will be updates on SAMHSA's 
reauthorization and legislation to reauthorize the Violence Against 
Women Act, as well as, a discussion on SAMHSA's National Registry of 
Evidenced-based Programs and Practices.
    Attendance by the public will be limited to space available. Public 
comments are welcome. Please communicate with the individual listed as 
contact below to make arrangements to comment or to request special 
accommodations for persons with disabilities.
    Substantive program information and a roster of Committee members 
may be obtained by accessing the SAMHSA Advisory Councils' Web site 
(http://www.samhsa.gov) as soon as possible after the meeting or by 
communicating with the contact whose name and telephone number are 
listed below. The transcript for the session will also be available on 
the SAMHSA Advisory Councils' website as soon as possible after the 
meeting.


[[Page 54953]]


    Committee Name: Substance Abuse and Mental Health Services 
Administration Advisory Committee for Women's Services.
    Meeting Dates: Monday, September 26, 2005 9 a.m.-5 p.m. Tuesday, 
September 27, 2005 9 a.m.-12 Noon.
    Place: 1 Choke Cherry Road, Sugarloaf Conference Room, 
Rockville, MD 20857.
    Contact: Carol Watkins, Executive Secretary, 1 Choke Cherry 
Road, Room 8-1002, Rockville, MD 20857, Telephone: (240) 276-2254, 
Fax: (240) 276-2252, E-mail: <a href="/cdn-cgi/l/email-protection#dbb8baa9b4b7f5acbaafb0b2b5e99ba8bab6b3a8baf5b3b3a8f5bcb4ad"><span class="__cf_email__" data-cfemail="016260736e6d2f7660756a686f334172606c6972602f6969722f666e77">[email protected]</span></a>.

    Dated: September 12, 2005.
Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. 05-18531 Filed 9-16-05; 8:45 am]
BILLING CODE 4162-20-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
STATE v. Michael Antonio BULLOCK.

No. 194A16-1.

Supreme Court of North Carolina.

May 23, 2016.

Jon H. Hunt, Assistant Appellate Defender, for Bullock, Michael Antonio.

Kristin Jo Uicker, Raleigh, Attorney at Law, for State of North Carolina.

Roger A. Echols, District Attorney.

*4The following order has been entered on the motion filed on the 23rd of May 2016 by State of NC for Temporary Stay:

> "Motion Allowed by order of the Court in conference, this the 23rd of May 2016."
**Exhibit 23.1****CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**We consent to the incorporation by reference in Registration Statement No. 333-91597 on FormS-3 and Registration Statement Nos. 333-31108, 333-61472 and 333-88970 each on Form S-8, of ourreport dated March 16, 2007, relating to the financial statements of The Cronos Group, appearingin this Annual Report on Form 10-K of The Cronos Group for the year ended December 31, 2006.We consent to the incorporation by reference in Registration Statement No. 333-91597 of The CronosGroup on Form S-3 and Registration Statement Nos. 333-31108, 333-61472 and 333-88970 of The CronosGroup each on Form S-8, of our report dated March 16, 2007 relating to the financial statements ofCF Leasing Limited, appearing in this Annual Report on Form 10-K of The Cronos Group for the yearended December 31, 2006./s/ DELOITTE & TOUCHE LLP
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3853 Introduced in House (IH)]

113th CONGRESS
  2d Session
                                H. R. 3853

  To amend the Patient Protection and Affordable Care Act to prohibit 
  Government contributions under the Federal employees health benefit 
   program towards Exchange health insurance coverage of Members of 
                               Congress.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 10, 2014

 Mr. Reed (for himself, Mr. Stutzman, and Mr. Southerland) introduced 
   the following bill; which was referred to the Committee on House 
                             Administration

_______________________________________________________________________

                                 A BILL

 
  To amend the Patient Protection and Affordable Care Act to prohibit 
  Government contributions under the Federal employees health benefit 
   program towards Exchange health insurance coverage of Members of 
                               Congress.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``No Special Treatment for Members of 
Congress Act''.

SEC. 2. NO GOVERNMENT CONTRIBUTIONS UNDER FEHB TOWARDS EXCHANGE HEALTH 
              INSURANCE COVERAGE OF MEMBERS OF CONGRESS.

    (a) In General.--Section 1312(d)(3)(D) of the Patient Protection 
and Affordable Care Act (42 U.S.C. 18032(d)(3)(D)) is amended by adding 
at the end the following new clause:
                            ``(iii) No government contribution under 
                        fehb.--No Government contribution under section 
                        8906 of title 5, United States Code, shall be 
                        provided on behalf of an individual who is a 
                        Member of Congress for coverage made available 
                        to such individual pursuant to this 
                        subparagraph.''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
apply as if included in the enactment of section 1312(d)(3)(D) of the 
Patient Protection and Affordable Care Act (42 U.S.C. 18032(d)(3)(D)).
                                 <all>
```